Post-award notification.pdf

Post-Award Public Notice

Posted Pursuant to 41 U.S.C. § 2304(f)(5) and RFO FAR Subpart 6.3 / FAR 6.305

Notice Type: Award Notice — Justification for Other Than Full and Open Competition

Date Posted: 09/24/2026

Contract Award Date: 09/23/2026

SECTION 1 — CONTRACT INFORMATION

Field Information

Agency U.S. Department of Health and Human Services (HHS)

Contracting Activity U.S. Food and Drug Administration (FDA), OƯice of Acquisitions and Grants Services (OAGS)

Contract Number 75F40126P00379

Contract Type Firm-Fixed-Price (FFP) Purchase Order

Contractor Name Tradespace Inc.

Contractor Address 30 Fair Oaks ST APT 3, San Francisco, California, 94110

Contractor UEI SAM UQ4QBB269XN5

Total Contract Value $ 82,000.00

Period of Performance

Base Year: 09/30/2026-09/29/2027 Option Year 1: 09/30/2027 through 9/29/2028 Option Year 2: 09/30/2028 through 9/29/2029 Option Year 3: 09/30/2029 through 9/29/2030

PSC Code DA10 — IT and Telecom - Business Application /Application Development Software as a Service

NAICS Code 513210 — - Software Publishers

Small Business Size Standard $47 million

Field Information

Acquisition Procedure FAR Part 12 — Commercial Products and Commercial Services (RFO)

SECTION 2 — STATUTORY AUTHORITY FOR OTHER THAN FULL AND OPEN

COMPETITION

This contract was awarded without full and open competition pursuant to the authority of:

41 U.S.C. § 3304(a)(1) — Only one responsible source and no other supplies or services will satisfy agency requirements

RFO FAR 6.103-1 (formerly FAR 6.302-1) — Only one responsible source

SECTION 3 — DESCRIPTION OF SUPPLIES ACQUIRED

The FDA awarded a sole source, firm-fixed-price purchase order to Tradespace, Inc. for the acquisition of the following brand-name commercial items:

Description Quantity/Media Due Date Onboarding Plan One (1) electronic copy (.pdf or .docx) delivered to COR via email 3 business days after award

Platform Access Confirmation

One (1) authorized FDA TTP user account, including written confirmation that all accounts are active and accessible

7 business days after award

Training Completion Summary

Summary of training sessions held, attendees, topics covered, and self-service resource links

Within 14 days of last training session

Technical Support 1 12 months Market Intelligence and Commercialization Support

1 12 months

The items meet the following technical requirements:

a) Platform Access and Licensing The Contractor shall provide 1 (one) authorized FDA TTP staƯ with access to the platform for the full period of performance. The Contractor shall provision all user accounts within 7 business days of contract award.

Access shall include, at minimum, the following standard platform capabilities:

• Real-time market intelligence data, including industry trends, investment activity, product alignment analysis, and competitor IP monitoring.

• Market analysis reports associated with invention disclosures to support patenting and licensing decisions.

• Patent and portfolio analytics, including prior art search support and multi-jurisdictional docketing visibility.

• Licensing partner identification tools that match FDA inventions to potential commercial partners based on market and IP data.

• Reporting and analytics dashboards for portfolio management and strategic planning.

b) Onboarding and Implementation The Contractor shall deliver a written onboarding plan to the Contracting OƯicer's Representative (COR) within 3 business days of contract award. The onboarding plan shall include account configuration steps, user provisioning procedures, a description of available data sources and capabilities, and a schedule for initial training. The Contractor shall configure the platform to reflect FDA TTP workflows and use cases to the extent supported by standard platform features.

c) Training The Contractor shall provide initial platform training for all authorized FDA TTP users.

Training shall be delivered via live virtual sessions and shall cover, at minimum: platform navigation, market intelligence search and filtering, invention marketability assessment workflows, commercialization report generation, licensing partner identification, and portfolio analytics. The Contractor shall also maintain access to self-service training resources—including video tutorials, user guides, and a searchable knowledge base— throughout the period of performance.

d) Market Intelligence and Commercialization Support The Contractor shall ensure that the platform provides continuous access to updated market intelligence data throughout the period of performance. The Contractor shall maintain and refresh underlying data sources—including patent databases, product and investment databases, and industry market data—on a regular basis.

e) Technical Support The Contractor shall provide dedicated technical support to authorized FDA TTP users throughout the period of performance. Support shall be available during standard business hours (8:00 AM – 6:00 PM Eastern Time, Monday through Friday, excluding federal holidays).

The Contractor shall assign a dedicated Account Manager as the primary point of contact for FDA. Platform updates, bug fixes, and new feature releases shall be provided at no additional cost during the period of performance.

f) Security Compliance Documentation The Contractor shall provide all security documentation required by FDA's OƯice of Information Management and Technology (OIMT).

SECTION 4 — RATIONALE FOR OTHER THAN FULL AND OPEN COMPETITION

A. Only One Responsible Source

Only Tradespace, Inc. was capable of meeting the full combination of requirements, including IP lifecycle management, real-time market intelligence integrated with patent analytics, automated commercialization report generation, and licensing partner identification specifically tailored to government technology transfer workflows.

B. No Technically Equivalent Substitute

Market research conducted by the FDA prior to award confirmed that no other vendor capable of meeting all the Government’s needs.

SECTION 5 — EFFORTS TO OBTAIN COMPETITION

In accordance with RFO FAR 6.103-1 and prior to award, the FDA posted a Notice Of Intent For A Sole Source and Combined Synopsis/Solicitation on SAM.gov on 09/18/2026. No responses, except Tradespace, were received demonstrating the capability to meet the Government's requirements.

SECTION 6 — PRICE REASONABLENESS

The Contracting OƯicer determined that the price of $ 82,000.00 is fair and reasonable based on comparison with the invoices provided by Tradespace of the same items sold to other commercial entities.

SECTION 7 — MARKET RESEARCH

Market research was conducted by the FDA in accordance with RFO FAR Part 10. The market research confirmed that no other vendor can meet the Government's needs.

SECTION 8 — ACTIONS TO FOSTER FUTURE COMPETITION

The FDA will take the following actions to foster competition for future requirements:

1. Continue to monitor the commercial marketplace for the emergence of alternatives capable of meeting FDA's technical requirements;

2. Engage in market outreach and industry days as appropriate; and

3. Evaluate whether future requirements can be structured to promote competition at the time of any follow-on procurement.

SECTION 9 — CONTRACTING OFFICER CERTIFICATION

I certify that this justification is accurate and complete to the best of my knowledge and belief.

Min Jie Zeng

Contracting OƯicer

U.S. Food and Drug Administration

OƯice of Acquisitions and Grants Services

09/24/2026